by Nicole Kuchinsky | Feb 29, 2016
Japan is making bold moves to redefine how cell therapies make it to market, and the world is taking notice. In late January, the Japan External Trade Organization (JETRO) collaborated with the Centre for Commercialization of Regenerative Medicine (CCRM) to host a...
by Stacey Johnson | Feb 26, 2016
Whether you call it cotton candy, candy floss or the original name for it “fairy floss,” I’m going to assume you’ve never called it “a tool for creating artificial blood vessels.” (Too long and not very appetizing.) Nevertheless, Dr. Leon Bellan, Vanderbilt...
by Mark Curtis | Feb 22, 2016
Welcome to your update from the clinic for the month of January. It was a quiet month in the clinic. However, we did see some clearances for various clinical studies, including Fate’s ProTmune in GvHD and Pluristem’s PLX-R18 in hematopoietic recovery following bone...
by Stacey Johnson | Feb 19, 2016
I had the pleasure of talking about my career to my daughter’s class when she was in grade 5. In an effort to keep the kids awake, I avoided a potentially sleep-inducing talk about corporate communications and instead focused most of my presentation on giving a simple...
by Mark Curtis | Feb 18, 2016
Welcome to your Cell Therapy Deal Review for the month of January. Things got off to a quick start with a number of cell-based immunotherapy companies announcing deals and research collaborations out of the gate, including a third acquisition by Juno. Juno...
by Nicole Kuchinsky | Feb 17, 2016
Cell therapy is not a new idea. Bone marrow transplantation—the first ever cell therapy—has been around since the 1950s. Over half a century of research has brought important advancements, yet this technology has struggled to make it to prime time. Understandably,...
by Stacey Johnson | Feb 12, 2016
Are you a glass half full or half empty kind of person? If you’re the former, and you think more is better, being inclusive and diverse benefits humanity, and that children are our future, then this should be in your sweet spot (meaning “an optimum point or...
by Hamideh Emrani | Feb 10, 2016
Another in the series: “What drives research in the field of biomaterials?” “What makes Canada cool?” asks Dan Taekema of The Toronto Star, and among the handful of influential figures that he writes about is the “rock star” researcher, Professor Molly Shoichet. I was...
by Stacey Johnson | Feb 5, 2016
According to the World Health Organization, there were 8.2 million cancer related deaths in 2012 so by my calculations, that’s over 22,000 each day. Cancer has been on my mind a lot this week, and not just because yesterday was #WorldCancerDay. On February 1st, the...
Comments